PHC Corporation - 85-degreeC Compact Non-Freon Ultra-Low Temperature Freezer Aiming to Contribute to Reducing Environmental Impact, Contributing to reducing running costs of research facilities

PHC Corporation Biomedica Division (Head office: Minato-ku, Tokyo; President: Shinro Nakamura; hereinafter referred to as 'PHCbi') has announced that it will reduce the burden on the global environment and save energy for pharmaceutical companies, research facilities, and medical institutions.

We are pleased to inform you that we have released a -85-degreeC compact non-Freon ultra-low temperature freezer (model number: MDF-DC102VH-PJ [84L] / DC202VH-PJ [180L]) (1) that pursues improved performance.

Aiming to realize the Paris Agreement adopted in 2015 to solve the problem of climate change, the world is promoting efforts with the goal of 'Carbon Neutral by 2050'. In addition to the pressing need to reduce man-made emissions of greenhouse gases, mainly carbon dioxide, fuel prices are soaring around the world. Masu.

The newly released 'MDF-DC102VH-PJ/DC202VH-PJ' not only efficiently and safely store valuable biological samples and pharmaceuticals for researchers involved in drug discovery and life science research for a long period of time, but also uses non-fluorocarbon refrigerants. This is a -85-degreeC compact non-Freon ultra-low temperature freezer that contributes to reducing the burden on the global environment by reducing power consumption. By adopting a highly energy-efficient natural refrigerant (2) and installing a new high-output type compressor that reduces the total amount of refrigerant charged, up to 41% energy savings (4) compared to conventional models (3). ) has been realized. Reducing power consumption in research facilities and medical institutions contributes to lower running costs and prevention of global warming, while the use of natural refrigerants with low GWP values (global warming potential) helps prevent ozone depletion. Contribute.

In addition, by expanding the controllable temperature range from -85-degreeC to -60-degreeC to -85-degreeC to -40-degreeC, a wider range of samples, such as biopharmaceuticals, can be stored frozen. In addition, since various operating data such as the temperature inside the refrigerator and alarm history can be transferred to a USB memory, it is useful for quality control of stored items.

Since PHCbi launched a medicinal refrigerator in Japan in 1966, we have been working on the development of a wide range of life science equipment centered on preservation and culture equipment. The purpose of this new product is to expand the lineup of CFC-free ultra-low temperature freezers, one of our main products, and to promote the realization of the PHC Group's medium-term management plan 'Value Creation Plan (FY22-FY25)' (5).

Nobuo Nakamura, President and CEO of PHC Corporation and General Manager of the Biomedica Division, said, 'In 2018, we launched the VIP ECO (vertical CFC-free ultra-low temperature freezer), which uses natural refrigerants and an inverter compressor to significantly reduce power consumption. 6), and in 2022, we will release 'VIP ECO SMART (7)', which achieves even greater energy savings , and its excellent energy-saving performance has been praised by customers around the world. With the growth of the market for biopharmaceuticals and other biopharmaceuticals, the demand for compact ultra-low temperature freezers in clinical settings is expected to increase. The newly released compact CFC-free ultra-low temperature freezer will not only help preserve valuable medicines and specimens for long periods of time, but will also help realize the SDGs. Based on the PHC Group's sustainability initiatives (8) , we hope to contribute to the realization of a decarbonized society by providing products with superior energy-saving performance.

About PHC Corporation Biomedica Division>

Established in 1969, PHC Corporation is a Japanese operating subsidiary of PHC Holdings Corporation (Code: 6523, TSE Prime), which operates as a global healthcare company. The Biomedica Division, which handles life science business, has a business brand of 'PHCbi' and works with scientists in approximately 110 countries and regions through the provision of research and medical support equipment and services, including ultra-low temperature freezers and CO 2 incubators. We are working to support researchers.

About PHC Holdings Co., Ltd.

PHC Holdings Corporation (stock code: 6523 TSE Prime) is a global healthcare company whose management philosophy is to create new value for all people who desire good health and contribute to the creation of a prosperous society. Its affiliates include PHC Corporation, Ascensia Diabetes Care Holdings, Epredia Holdings, LSI Medience Co., Ltd., and Weemex Co., Ltd., which develop, manufacture, and sell in the business areas of diabetes management, healthcare solutions, and diagnostics and life sciences. , we are providing services. Consolidated revenue in fiscal 2022 will be 356.4 billion yen, and our products and services are used by customers in more than 125 countries and regions around the world. PHC Group is the collective name for PHC Holdings Corporation and its operating subsidiaries.

Contact:

Tel: [phone]

Email: [e-mail]

(C) 2023 Electronic News Publishing, source ENP Newswire